{"id":3325,"date":"2019-09-23T10:32:25","date_gmt":"2019-09-23T08:32:25","guid":{"rendered":"http:\/\/www.cube-labs.com\/?p=3325"},"modified":"2019-09-23T10:32:25","modified_gmt":"2019-09-23T08:32:25","slug":"antonio-falcone-in-cube-labs-team","status":"publish","type":"post","link":"https:\/\/pazlab.cube-labs.com\/it\/news\/antonio-falcone-in-cube-labs-team\/","title":{"rendered":"Antonio Falcone in Cube-Labs Team"},"content":{"rendered":"<p><strong>Antonio Falcone<\/strong>, began a new professional adventure at <strong>Cube-Labs<\/strong> as an <strong>Equity Partner with the function of CIO<\/strong> (<strong>Chief Investment Officer<\/strong>). He will work alongside <strong>Filippo Surace<\/strong> and <strong>Renato del Grosso<\/strong>, respectively Founder and Co-Founder of Cube-Labs, assisting in the development of his sector. <\/p>\n\n\n\n<p><strong>Falcone, Managing Director from 2014 to last August of<\/strong> <strong>Principia SGR<\/strong>,<strong> the most important Italian VC (Venture Capital) Fund in the health sector<\/strong> (more than 200 million euro raised), has <strong>more than twenty years&#8217; expertise<\/strong> in the financial sector. His most significant experiences <strong>include Banca Sella, Deutsche Bank, Unicredit, Inarcassa and Kairos<\/strong>. <\/p>\n\n\n\n<p>In recent months <strong>Cube-Labs<\/strong> has embarked on <strong>a path that will lead to the raising of capital from either with private investors or through an IPO perspective<\/strong> (<strong>assisted by Equita sim<\/strong>), being the <strong>first Italian company to own 11 Start-Ups and early-stage academic companies operating in the biotech<\/strong>, <strong>medical and nutraceutical sectors<\/strong>, with the aim of growing to 25 subsidiary companies by 2023 thanks to its listing on the Stock Exchange. <\/p>\n\n\n\n<p><br> \u201c <strong>I am happy to take part in this new and important challenge<\/strong> &#8211; said Antonio Falcone &#8211; aimed at increasing early-stage financing in Italy, where there is no investment tool in the sector open to the market. Today, also thanks to the Italian Growth Decree, <strong>there is the possibility to introduce in Italy financial instruments managed by qualified operators who can invest in a sector with high growth and high potential, such as the biomedical research one<\/strong>. As the cases of IP Group and Imperial Innovations show abroad, <strong>through listing on the stock exchange you can raise capital by giving back to finance the role of a transmission belt between savings<\/strong> (private and institutional) and companies that enhance <strong>intellectual property<\/strong>. \u201c<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter\"><img decoding=\"async\" src=\"http:\/\/www.cube-labs.com\/wp-content\/uploads\/2019\/09\/Antonio-Falcone.png\" alt=\"\" class=\"wp-image-3329\"\/><figcaption>Antonio Falcone, Chief Investment Officer of Cube-Labs<\/figcaption><\/figure><\/div>","protected":false},"excerpt":{"rendered":"<p>Antonio Falcone, began a new professional adventure at Cube-Labs as an Equity Partner with the function of CIO (Chief Investment Officer). He will work alongside Filippo Surace and Renato del Grosso, respectively Founder and Co-Founder of Cube-Labs, assisting in the development of his sector. Falcone, Managing Director from 2014 to last August of Principia SGR, [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":""},"categories":[48],"tags":[],"class_list":{"0":"post-3325","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-news"},"acf":[],"_links":{"self":[{"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/posts\/3325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/comments?post=3325"}],"version-history":[{"count":0,"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/posts\/3325\/revisions"}],"wp:attachment":[{"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/media?parent=3325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/categories?post=3325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/tags?post=3325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}